• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q3 2024

    10/23/24 7:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance
    Get the next $CME alert in real time by email
    • Record revenue of $1.6 billion
    • Record quarterly ADV of 28.3 million contracts - the second consecutive quarter of volume, open interest growth across every asset class

    CHICAGO, Oct. 23, 2024 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the third quarter of 2024.

    The company reported revenue of $1.6 billion and operating income of $1.0 billion for the third quarter of 2024. Net income was $913 million and diluted earnings per common share were $2.50. On an adjusted basis, net income was $977 million and diluted earnings per common share were $2.68. Financial results presented on an adjusted basis for the third quarter of 2024 and 2023 exclude certain items, which are detailed in the reconciliation of non-GAAP results.1

    "Q3 2024 was the best quarter in CME Group history, with records across volume, revenue, adjusted operating income, adjusted net income and adjusted earnings per share," said Terry Duffy, Chairman and Chief Executive Officer, CME Group. "This marks the second consecutive quarter of volume and open interest increases across every asset class. Our financial product volumes rose 28%, reflecting a 36% jump in interest rates to a record ADV of 14.9 million contracts. This was driven by a 35% rise in SOFR futures to a record ADV of 4.1 million contracts and 31% growth in Treasuries to a record ADV of 8.4 million contracts. In addition, our commodities volume was up 20%, options increased 27% and international ADV was a record 8.4 million contracts."

    Third-quarter 2024 ADV was a record 28.3 million contracts, including record non-U.S. ADV, with EMEA up 30% and Asia up 28% versus the same period last year.

    1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials.

    Clearing and transaction fees revenue for third-quarter 2024 totaled $1.3 billion. The total average rate per contract was $0.666. Market data revenue totaled $178 million for third-quarter 2024.

    As of September 30, 2024, the company had approximately $2.6 billion in cash (including $250 million deposited with Fixed Income Clearing Corporation, which is included in other current assets) and $3.4 billion of debt. The company paid dividends during the third quarter of approximately $419 million. The company has returned approximately $25.6 billion to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.

    CME Group will hold a Q&A conference call to discuss third-quarter 2024 results at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on the Investor Relations section of CME Group's website at investor.cmegroup.com under Events & Presentations. An archived recording will be available for up to two months after the call.

    As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. 

    CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.

    Statements in this press release that are not historical facts are forward-looking statements.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk through third parties, including risks related to the performance, reliability and security of technology used by our third-party providers and third-party providers that our clients rely on; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases in contract volume and order messaging traffic and to implement enhancements without failure or degradation of the performance of our trading and clearing systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including those associated with the performance of our joint ventures with S&P Dow Jones (S&P Dow Jones Indices LLC) in index services and in trade processing/post trade services (OSTTRA), our primary business and distribution partners' actions and our partnership with Google Cloud; variances in earnings on cash accounts and collateral that our clearing house holds for its clients; impact of CME Group pricing and incentive changes; impact of aggregation services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms of intellectual property and index rights; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry, channel partner and customer consolidation and/or concentration; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates, borrowing costs, or changes in tax policy; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings.  For a detailed discussion and additional information concerning these and other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission ("SEC") on February 28, 2024, under the caption "Risk Factors".

     

    CME Group Inc. and Subsidiaries

    Consolidated Balance Sheets

    (in millions)







    September 30, 2024



    December 31, 2023

    ASSETS









    Current Assets:









    Cash and cash equivalents



    $             2,322.1



    $             2,912.0

    Marketable securities



    112.3



    111.7

    Accounts receivable, net of allowance



    629.4



    535.6

    Other current assets (includes $6.5 and $5.2 in restricted cash)



    622.0



    1,138.4

    Performance bonds and guaranty fund contributions



    99,457.0



    90,192.5

    Total current assets



    103,142.8



    94,890.2

    Property, net of accumulated depreciation and amortization



    386.2



    409.5

    Intangible assets—trading products



    17,175.3



    17,175.3

    Intangible assets—other, net



    2,892.2



    3,050.2

    Goodwill



    10,514.1



    10,495.3

    Other assets



    3,684.5



    3,685.6

    Total Assets



    $          137,795.1



    $          129,706.1

    LIABILITIES AND EQUITY









    Current Liabilities:









    Accounts payable



    $                129.9



    $                 90.6

    Short-term debt



    749.7



    —

    Other current liabilities



    485.2



    3,133.8

    Performance bonds and guaranty fund contributions



    99,457.0



    90,192.5

    Total current liabilities



    100,821.8



    93,416.9

    Long-term debt



    2,677.7



    3,425.4

    Deferred income tax liabilities, net



    5,310.0



    5,327.7

    Other liabilities



    769.4



    798.2

    Total Liabilities



    109,578.9



    102,968.2

    Total CME Group Shareholders' Equity



    28,216.2



    26,737.9

    Total Liabilities and Equity



    $          137,795.1



    $          129,706.1

     

    CME Group Inc. and Subsidiaries

    Consolidated Statements of Income

    (dollars in millions, except per share amounts; shares in thousands)







    Quarter Ended 

    September 30,



    Nine Months Ended 

    September 30, 





    2024



    2023



    2024



    2023

    Revenues

















    Clearing and transaction fees



    $   1,297.1



    $   1,085.5



    $  3,755.9



    $  3,404.0

    Market data and information services



    178.2



    167.6



    528.6



    496.5

    Other



    109.1



    84.7



    320.3



    239.1

    Total Revenues



    1,584.4



    1,337.8



    4,604.8



    4,139.6

    Expenses

















    Compensation and benefits



    218.8



    205.5



    629.5



    615.7

    Technology



    66.6



    55.6



    190.1



    160.2

    Professional fees and outside services



    31.0



    32.2



    98.8



    108.3

    Amortization of purchased intangibles



    55.7



    57.2



    166.4



    171.0

    Depreciation and amortization



    28.2



    31.1



    87.0



    95.3

    Licensing and other fee agreements



    97.6



    79.5



    271.4



    242.4

    Other



    62.3



    56.5



    177.2



    174.2

    Total Expenses



    560.2



    517.6



    1,620.4



    1,567.1

    Operating Income



    1,024.2



    820.2



    2,984.4



    2,572.5

    Non-Operating Income (Expense)

















    Investment income



    1,026.8



    1,272.5



    3,142.6



    4,198.4

    Interest and other borrowing costs



    (40.2)



    (39.6)



    (120.2)



    (119.7)

    Equity in net earnings of unconsolidated subsidiaries



    86.1



    76.8



    259.7



    230.1

    Other non-operating income (expense)



    (920.0)



    (1,155.6)



    (2,821.7)



    (3,733.7)

    Total Non-Operating Income (Expense)



    152.7



    154.1



    460.4



    575.1

    Income before Income Taxes



    1,176.9



    974.3



    3,444.8



    3,147.6

    Income tax provision



    264.1



    224.1



    793.6



    736.0

    Net Income



    $     912.8



    $     750.2



    $  2,651.2



    $  2,411.6

    Net Income Attributable to Common Shareholders of CME

    Group



    $     901.3



    $     740.8



    $  2,617.8



    $  2,381.3



















    Earnings per Share Attributable to Common Shareholders

    of CME Group:

















    Basic



    $       2.51



    $       2.06



    $      7.29



    $      6.63

    Diluted



    2.50



    2.06



    7.27



    6.62

    Weighted Average Number of Common Shares:

















    Basic



    359,400



    359,020



    359,329



    358,965

    Diluted



    359,989



    359,619



    359,899



    359,448

     

    CME Group Inc. and Subsidiaries

    Quarterly Operating Statistics







    3Q 2023



    4Q 2023



    1Q 2024



    2Q 2024



    3Q 2024

    Trading Days



    63



    63



    61



    63



    64

     

    Quarterly Average Daily Volume (ADV)(1)

    CME Group ADV (in thousands)



    Product Line



    3Q 2023



    4Q 2023



    1Q 2024



    2Q 2024



    3Q 2024

    Interest rates



    10,967



    13,348



    13,839



    12,894



    14,881

    Equity indexes



    6,353



    6,922



    6,856



    6,779



    7,407

    Foreign exchange



    942



    1,007



    984



    1,075



    1,089

    Energy



    2,126



    2,158



    2,412



    2,447



    2,571

    Agricultural commodities



    1,433



    1,469



    1,596



    1,877



    1,614

    Metals



    528



    609



    675



    868



    728

    Total



    22,349



    25,513



    26,360



    25,941



    28,289

    Venue





















    CME Globex



    20,838



    23,503



    23,985



    24,143



    26,199

    Open outcry



    713



    1,126



    1,333



    825



    1,096

    Privately negotiated



    797



    885



    1,043



    974



    994

    Total



    22,349



    25,513



    26,360



    25,941



    28,289

     

    Quarterly Average Rate Per Contract (RPC)(1)

    CME Group RPC

     



    Product Line



    3Q 2023



    4Q 2023



    1Q 2024



    2Q 2024



    3Q 2024

    Interest rates



    $        0.508



    $        0.488



    $        0.486



    $        0.484



    $        0.468

    Equity indexes



    0.625



    0.616



    0.641



    0.628



    0.616

    Foreign exchange



    0.791



    0.806



    0.787



    0.754



    0.744

    Energy



    1.324



    1.338



    1.334



    1.297



    1.246

    Agricultural commodities



    1.328



    1.361



    1.356



    1.366



    1.346

    Metals



    1.492



    1.502



    1.556



    1.511



    1.540

    Average RPC



    $        0.707



    $        0.682



    $        0.695



    $        0.708



    $        0.666























    1. ADV and RPC includes futures and options on futures only.





     

    CME Group Inc. and Subsidiaries

    Reconciliation of GAAP to non-GAAP Measures

    (dollars in millions, except per share amounts; shares in thousands)







    Quarter Ended 

    September 30,



    Nine Months Ended 

    September 30, 





    2024



    2023



    2024



    2023

    Net Income



    $     912.8



    $     750.2



    $  2,651.2



    $  2,411.6

    Restructuring and severance(1)



    6.7



    12.6



    10.3



    14.9

    Amortization of purchased intangibles(2)



    69.3



    70.7



    206.9



    211.3

    Strategic transaction-related costs (credits)



    —



    —



    0.8



    (2.2)

    Real estate-related costs (credits)



    (1.0)



    —



    (2.0)



    —

    Foreign exchange transaction (gains) losses



    4.3



    (1.9)



    2.2



    (0.1)

    Unrealized and realized (gains) losses on investments



    —



    2.0



    (11.7)



    (71.8)

    Unrealized and realized (gains) losses on assets



    —



    —



    0.8



    0.4

    Litigation matters or settlements



    1.2



    2.0



    1.2



    2.0

    Income tax effect related to above



    (16.3)



    (17.6)



    (41.3)



    (28.6)

    Other income tax items



    —



    —



    1.9



    (0.8)

    Adjusted Net Income



    $     977.0



    $     818.0



    $  2,820.3



    $  2,536.7



















    Adjusted Net Income Attributable to Common Shareholders of

    CME Group



    $     964.7



    $     807.8



    $  2,784.8



    $  2,504.8



















    Earnings per Share Attributable to Common Shareholders of CME Group:









         Basic



    $       2.51



    $       2.06



    $      7.29



    $      6.63

         Diluted



    2.50



    2.06



    7.27



    6.62



















    Adjusted Earnings per Share Attributable to Common Shareholders of CME Group:









         Basic



    $       2.68



    $       2.25



    $      7.75



    $      6.98

         Diluted



    2.68



    2.25



    7.74



    6.97



















    Weighted Average Number of Common Shares:

















         Basic



    359,400



    359,020



    359,329



    358,965

         Diluted



    359,989



    359,619



    359,899



    359,448

    Preferred shares(3)



    4,584



    4,584



    4,584



    4,584



    1. Includes $5.3 million of compensation expense due to a law change for vacation carryover in 2024.

    2. Includes $11.1 million and $33.2 million of amortization of purchased intangibles (net of tax) at OSTTRA and $2.5 million and $7.5 million of amortization of purchased intangibles at S&P Dow Jones Indices LLC in the third quarter and first nine months of 2024. This is reported in Equity in net earnings of unconsolidated subsidiaries on the Consolidated Statements of Income.

    3. Preferred shares have similar rights as common shares without voting rights.

    CME-G

    Cision View original content:https://www.prnewswire.com/news-releases/cme-group-inc-reports-all-time-record-revenue-adjusted-operating-income-adjusted-net-income-and-adjusted-earnings-per-share-for-q3-2024-302283962.html

    SOURCE CME Group

    Get the next $CME alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CME

    DatePrice TargetRatingAnalyst
    4/8/2025$301.00Equal-Weight → Overweight
    Morgan Stanley
    3/10/2025$287.00Mkt Perform → Outperform
    Raymond James
    1/6/2025$255.00 → $250.00Buy → Neutral
    Citigroup
    10/8/2024$244.00Buy → Neutral
    Redburn Atlantic
    9/27/2024$235.00Sector Perform
    RBC Capital Mkts
    9/26/2024$221.00Hold
    TD Cowen
    9/3/2024$212.00 → $177.00Neutral → Underperform
    BofA Securities
    6/21/2024$206.00 → $187.00Neutral → Underweight
    JP Morgan
    More analyst ratings